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Introduction
The endothelial blood–brain barrier (BBB), composed of the 
highly specialized central nervous system (CNS) microvascular 
endothelial cells, and the epithelial blood–cerebrospinal fluid 
barrier (BCSFB), composed of the choroid plexus epithelial cells, 
protect the CNS from the constantly changing milieu in the blood-
stream as well as infections and toxins, and are thus essential for 
maintaining CNS homeostasis (Fig. 1). Work on how these bar-
riers prevent paracellular diffusion of harmful elements into the 
CNS usually focuses on characterization of the highly complex 
tight junctions (TJs) of the BBB, which resemble epithelial TJs 
(Kniesel et al., 1994; Liebner et al., 2000b), and the unique par-
allel running TJ strands of the BCSFB (Engelhardt et al., 2001; 
Wolburg and Paulus, 2010). Yet, formation of TJs generally re-
quires the existence of adherens junctions (AJs), and central 
to the organization of dynamic junctions is the continuous 
crosstalk between components of AJs and TJs, a fact often 
neglected by researchers studying the BBB and the BCSFB. 
AJs do certainly exist in these barriers and are established be-
tween neighboring cells by the homophilic interaction between 
the transmembrane proteins vascular endothelial cadherin 
(VE-cadherin) and epithelial cadherin (E-cadherin) in CNS 
endothelial and choroid plexus epithelial cells, respectively 
(Vorbrodt and Dobrogowska, 2003).
TJs and AJs are considered to have distinct functions. 
TJs regulate the diffusion of solutes and ions through the para-
cellular route, which is referred to as their “gate” function. TJs 
also establish a “fence” function by limiting the free move-
ments of lipids and proteins from the apical and basolateral 
cell surfaces, thus contributing to cell polarity (Dejana et al., 
2009). In addition to the TJs between two adjacent cells, a spe-
cial molecularly distinct TJ has been described at tricellular con-
tacts, where the corners of three endothelial or epithelial cells 
meet. Interestingly, these tricellular TJs exist in BBB endothe-
lial cells and BCSFB epithelial cells (Iwamoto et al., 2014), 
suggesting that tricellular TJs may be required for full barrier 
function of both types of brain barriers. Before TJ formation, 
AJs initiate cell-to-cell contacts and promote their maturation, 
maintenance, and plasticity, and regulate tensile forces. Yet, 
far less is known about the underlying role of AJs in regulating 
dynamics of cell–contacts and the establishment of cell polar-
ity at the brain barriers.
In epithelial cells, including the choroid plexus epithe-
lium, TJs are the most apical component of the junctional 
complex and thus clearly distinguishable from AJs. In endo-
thelial cells, however, localization of TJs and AJs is more vari-
able, and both junctional complexes appear intermingled, 
especially in brain endothelial cell-to-cell junctions (Schulze 
and Firth, 1993; Vorbrodt and Dobrogowska, 2003; Dejana et al., 
2009). Given that endothelial AJs in peripheral vascular beds 
play an important role in the control of vascular permeability 
(Giannotta et al., 2013), the contribution of these junctions to 
the integrity of BBB junctions during development, normal 
physiology, and disease should be elucidated. This is under-
scored by recent evidence demonstrating that the TJ protein 
zonula occludens 1 (ZO-1) is also a central regulator of endo-
thelial AJs (Tornavaca et al., 2015).
Unique intercellular junctional complexes between the 
central nervous system (CNS) microvascular endothelial 
cells and the choroid plexus epithelial cells form the endo-
thelial blood–brain barrier (BBB) and the epithelial blood–
cerebrospinal fluid barrier (BCSFB), respectively. These 
barriers inhibit paracellular diffusion, thereby protecting 
the CNS from fluctuations in the blood. Studies of brain 
barrier integrity during development, normal physiology, 
and disease have focused on BBB and BCSFB tight junc-
tions but not the corresponding endothelial and epithelial 
adherens junctions. The crosstalk between adherens junc-
tions and tight junctions in maintaining barrier integrity is 
an understudied area that may represent a promising tar-
get for influencing brain barrier function.
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Figure 1. Intercellular junctions between CNS microvascular endothelial cells forming the BBB and between choroid plexus epithelial cells forming the 
BCSFB. (A) Schematic of the localization of the brain barriers in parenchymal microvessels (B) and the choroid plexus in the ventricles (C) in a coronal 
brain section. (B) Localization (top) and molecular composition (bottom) of endothelial BBB AJs and TJs. AJs at the BBB are established by the homophilic 
interaction of cis dimers of transmembrane VE-cadherin in between adjacent endothelial cells. The cytoplasmic tail of VE-cadherin binds the armadillo family 
proteins p120- and -catenin, which, via interaction with -catenin and afadin (AF-6), mediate the link to the actin cytoskeleton. Nectins are transmembrane 
proteins belonging to the immunoglobulin (Ig) superfamily that form homodimers in cis and contribute to AJ formation by adhering to nectins on the adjacent 
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developing neuroectoderm, leading to the formation of an un-
differentiated vascular network. The molecular mechanisms 
driving brain angiogenesis are fairly well understood and have 
been summarized elsewhere (Engelhardt, 2003; Engelhardt and 
Liebner, 2014). How the barrier characteristics of CNS endo-
thelial cells, including their unique junctional complexes, ma-
ture during brain angiogenesis directed by factors from the 
developing neuroectoderm is less well understood.
The AJ component VE-cadherin is one of the first endothe-
lial cell–specific molecules expressed and required for endothe-
lial survival, blood vessel assembly, and stabilization (Carmeliet 
et al., 1999; Crosby et al., 2005). Interestingly, expression of 
VE-cadherin during brain angiogenesis has been observed to be 
relatively low (Breier et al., 1996), and instead cadherin-10 was 
abundantly present in AJs of CNS endothelial cells (Williams 
et al., 2005). In addition to VE-cadherin, N-cadherin is expressed 
in CNS endothelial cells during brain angiogenesis (Gerhardt 
et al., 2000). It accumulates at contact zones between endothe-
lial cells and the surrounding pericytes, where it regulates ex-
pression of VE-cadherin at the cell membrane (Luo and Radice, 
2005) and thus contributes to AJ maturation (Gerhardt et al., 
2000; Liebner et al., 2000a).
Stable AJs are considered to be required for the formation 
of TJs. A first hint to how endothelial AJs might induce TJ for-
mation at the molecular level is provided by the observation 
that VE-cadherin, through Akt activation and by inhibition of 
-catenin translocation to the nucleus, causes phosphorylation 
of the transcription factor forkhead box factor 1 (FoxO1), allow-
ing it to activate expression of the TJ protein claudin-5 (Taddei 
et al., 2008). This molecular link between AJs and TJs may also 
contribute to the formation of BBB TJs and thus barrier matura-
tion. This is supported by studies in zebrafish, where expression 
of claudin-5 and ZO-1 has been described in CNS microvessels 
starting at day 3 postfertilization, which was concomitant with 
the maturation of the BBB as determined by restricted permea-
bility to small and large size tracers (Jeong et al., 2008).
In contrast to our limited knowledge about the molecular 
mechanisms leading to AJ maturation at the BBB, the mecha-
nism of induction of expression of TJ proteins such as claudin-3, 
which are unique to CNS microvascular TJs, is much better 
CNS endothelial and epithelial AJs and 
TJs: Components and dynamics
At first glance the basic molecular makeup of BBB and BCSFB 
AJs and TJs resembles that of general endothelial and epithelial 
barriers (Fig. 1 and Table 1), and most work on the function of 
junctional molecules in regulating brain barriers has been extrapo-
lated from studies on their non-CNS counterparts. Yet, their high 
complexity and continuity distinguishes brain barrier TJs from 
peripheral TJs, and there are also important differences in their 
molecular makeup. In addition to the unique combinations of 
claudins observed in BBB and BCSFB TJs (Fig. 1 and Table 1), 
high expression levels of the integral TJ proteins occludin and 
claudin-5 and low expression levels of the integral AJ protein 
VE-cadherin characterize BBB endothelial cells (Table 1). This 
influences spatial arrangement of the cytoplasmic junctional 
scaffolding proteins, and thus affects characteristics of the an-
chorage of brain barrier junctional complexes to the cytoskel-
eton and, ultimately, the downstream signaling events regulating 
junctional dynamics (Table 1; Goddard and Iruela-Arispe, 2013; 
Citi et al., 2014). Such events include junctional protein phos-
phorylation, the continuous recycling of junctional molecules, 
and regulation of cytoskeletal dynamics by Rho family GTPases 
(summarized in Citi et al. [2014] and Goddard and Iruela-Arispe 
[2013]). Unfortunately, few of these processes have been ana-
lyzed specifically in brain endothelial or choroid plexus epithe-
lial cells. In particular, junction dynamics in brain endothelial 
cells could be very different, as pinocytotic activity is very low 
in brain endothelial cells. If endocytic activity was also low, this 
would slow down the recycling of junctional components such as 
cadherins. Furthermore, despite the generation of elegant mouse 
mutants to interrogate the specific role of individual junctional 
components in regulating AJ or TJ dynamics, careful analysis of 
brain barriers has yet to be performed in these models (Schulte 
et al., 2011; Wessel et al., 2014).
Maturation of brain barrier junctional 
complexes during development
Vascular junctions at the developing BBB. In mice, 
brain angiogenesis starts at 9.5 d postcoitum, when vascular 
sprouts invade from the perineural vascular plexus into the 
cell and binding AF-6 via their cytoplasmic tail, which connects nectin with the actin cytoskeleton. VE-cadherin can also bind to plakoglobin (-catenin) 
instead of to -catenin and thus connect endothelial AJs to the intermediate filaments in addition to the actin cytoskeleton. Although drawn separately in 
this figure, TJ strands that encircle the entire circumference of the CNS endothelial cells are intermingled with AJs. The transmembrane TJ proteins found 
to be localized in CNS endothelium are occludin, claudin-3, claudin-5, and claudin-12 as well as the junctional adhesion molecules (JAM) A, B, and C. 
Both claudins and JAMs mediate homophilic and heterophilic cis and trans interactions within their family, thus sealing the paracellular cleft between the 
adjacent endothelial cells. With the exception of claudin-12, the transmembrane TJ proteins carry a PDZ-binding motif in their carboxy terminus, through 
which they bind the scaffolding proteins ZO-1 and ZO-2 and, in the case of JAMs, also AF-6. These scaffolding proteins mediate the link to the actin 
cytoskeleton. ZO-1 has also been shown to bind to -catenin and F-actin and thus regulate AJs. Additional molecules found to be present in BBB cell-to-cell 
contacts are the Ig supergene family members ESAM, PECAM-1, and CD99. Linkage of TJ proteins to cell polarity complexes are omitted from this figure 
for reasons of simplicity. (C) Localization (top) and molecular composition (bottom) of the epithelial BCSFB established by choroid plexus epithelial cells. 
The microvessels within the highly vascularized choroid plexus are fenestrated capillaries that allow the free diffusion of water-soluble molecules across 
the vascular wall. Nevertheless, these vascular endothelial cells form AJs and TJs resembling those of peripheral vascular beds and are thus not drawn in 
detail here. AJs of the BCSFB are formed by the homophilic interaction of cis homodimers of the transmembrane protein E-cadherin. Via its cytoplasmic tail, 
E-cadherin binds the armadillo family members p120- and -catenin, which, in turn bind -catenin, linking E-cadherin to the epithelial actin cytoskeleton. 
Oriented apically relative to the AJs, the TJ strands of the BCSFB run in parallel around the entire circumference of the choroid plexus epithelial cells, with 
characteristic gaps that have been suggested to be important in the context of the transport functions of the choroid plexus. The transmembrane proteins that 
have been characterized as localized to the BCSFB TJs include occludin, claudin-1, claudin-2, claudin-3, and claudin-11 as well as JAM-A and JAM-C. Via 
their carboxy terminus, which harbors a PDZ domain binding motif, these proteins bind the scaffolding proteins ZO-1, ZO-2, and probably ZO-3, which 
link to the actin cytoskeleton. BM, basement membrane.
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Table 1. Expression and known function of junctional molecules at brain barriers
Junctional molecule General characteristics Brain barrier expression/localization Function in cell-to-cell contacts
Transmembrane AJ proteins
E-cadherin (uvomorulin, 
L-CAM)
Main integral membrane protein of epithelial 
AJs; member of classical cadherin family 
(Type I) mediating homophilic adhesions 
in cis and trans; links to actin cytoskeleton 
via catenin complex (Vestweber, 2015)
Basolateral localization in rat and chicken choroid 
plexus epithelium (Marrs et al., 1993) and epithe-
lial cells of benign human choroid plexus tumors 
(Figarella-Branger et al., 1995)
Core homophilic cell adhesion molecule 
of epithelial AJs, controls epithelial cell 
contact formation, barrier integrity, 
junctional plasticity, and cytoskeletal 
tension
VE-cadherin (cadherin-5) Main integral membrane protein of endothe-
lial AJs; member of the classical cadherin 
family (Type II) mediating homophilic 
adhesions in cis and trans; cytoplasmic 
domain links AJs via catenin complex 
to actin cytoskeleton and intermediate 
filaments (for review see Dejana and 
Vestweber, 2013)
At junctions in mouse CNS blood vessels even during 
embryonic development (Breier et al., 1996); local-
izes to junctions in rat and human brain microvessels 
(Vorbrodt and Dobrogowska, 2003)
Core homophilic cell adhesion molecule of 
endothelial AJs; controls endothelial cell 
survival, stabilization of blood vessel 
assembly, and vascular permeability 
(Carmeliet et al., 1999; Crosby et al., 
2005)
N-cadherin (cadherin-2) Transmembrane protein of the classical 
cadherin family (Type I)
Protein detected during early angiogenesis at the 
abluminal surface of eye and brain endothelial cells 
(Gerhardt et al., 1999)
Mediates pericyte–endothelial interactions 
during brain angiogenesis (Gerhardt  
et al., 2000)
VE-PTP Endothelial-specific phospho tyrosine phos-
phatase (VE-PTP)
VE-PTP-LacZ reporter expression observed in brain 
vessels during embryonic development (Bäumer et 
al., 2006)
Controls VE-cadherin phosphorylation and 
thus vascular junctional integrity and 
leukocyte diapedesis (Küppers et al., 
2014)
Nectin Member of the nectin family of the Ig 
superfamily; mediates homophilic or 
heterophilic interactions with other nectins 
(Indra et al., 2013); highly conserved 
cytoplasmic tail binds to the adaptor 
protein afadin (AF-6), linking nectins to 
actin cytoskeleton
Afadin observed in choroid plexus epithelium, suggest-
ing presence of nectin (Lagaraine et al., 2011)
Nectin–afadin complex involved in the 
formation of AJs (Ikeda et al., 1999) 
and TJs (Takai et al., 2003)
Transmembrane TJ proteins
Occludin Integral membrane protein localized exclu-
sively to TJs (Furuse et al., 1993); Type II 
transmembrane protein with a tetraspan-
ning Marvel (MAL and related proteins 
for vesicle trafficking and membrane link) 
motif; member of the TAMP family (like 
Tricellulin and MarvelD3) sharing the 
Marvel domain (Raleigh et al., 2010)
High expression and strong junctional localization in 
chicken brain microvessels (Furuse et al., 1993; 
Hirase et al., 1997) and in mouse BCSFB epithelial 
cells (Wolburg et al., 2001; Diez-Roux et al., 2011; 
Kratzer et al., 2012)
Links TJs to the actin cytoskeleton by 
recruiting scaffolding proteins of the 
MAGUK (membrane associated with 
a guanylyl kinase-like domain) family, 
such as zonula occludens 1 (ZO-1), 
ZO-2, and ZO-3 (Morita et al., 1999; 
Nasdala et al., 2002); regulates Ca2+ 
transport across BBB (Saitou et al., 
2000); localizes tricellulin to tricellular 
TJs (Ikenouchi et al., 2008); regulates 
paracellular permeability via its phos-
phorylation status (Raleigh et al., 2011)
Tricellulin TAMP family member (like occludin; Raleigh 
et al., 2010)
Restricted localization to tricellular TJs of BBB, recruited 
by the angulin/LSR-family (Furuse et al., 2014); ab-
sent in fenestrated endothelial cells of choroid plexus 
(Iwamoto et al., 2014)
Required for full barrier formation of in 
vitro cultured epithelial cells (Iwamoto 
et al., 2014)
Claudin-1 Member of the claudin family of tetraspan-
ning TJ-specific membrane proteins 
(Furuse et al., 1998); form the backbone 
of TJs by establishing homophilic and 
heterophilic interactions in cis and trans 
via their extracellular loops (Piontek et 
al., 2008); essential and sufficient to 
induce TJs in fibroblasts (Furuse et al., 
1998); PDZ-binding motif at the claudin 
carboxy terminus mediates interaction 
with the scaffolding proteins ZO-1, ZO-2, 
and ZO-3, which contributes to TJ strand 
organization (for review see Van Itallie 
and Anderson, 2014)
mRNA detected in mouse BCSFB (Kratzer et al., 2012) 
and protein localized to mouse BCSFB junctions 
(Wolburg et al., 2001); discrepant observations of 
expression in BBB: there is an absence of mRNA and 
protein in mouse brain parenchymal brain microves-
sels but a presence of protein in meningeal brain 
microvessels (Pfeiffer et al., 2011); protein detected 
in brain endothelial TJs (Haseloff et al., 2015)
Induces and seals TJs; regulates paracel-
lular movement of water (skin) and 
macromolecules (Furuse et al., 2002); 
claudin-1 overexpression in brain endo-
thelial cells of mouse models of neuroin-
flammation reduces BBB leakiness and 
ameliorates clinical disease (Pfeiffer  
et al., 2011).
Claudin-2 See general comments on claudin family 
above for claudin-1
mRNA and protein localizes to BCSFB (Wolburg et al., 
2001; Kratzer et al., 2012)
This pore forming claudin (Furuse et al., 
2001) regulates paracellular ion and 
water flow; claudin-2–deficient mice are 
viable, BCSFB function has not yet been 
analyzed (Muto et al., 2010)
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Junctional molecule General characteristics Brain barrier expression/localization Function in cell-to-cell contacts
Claudin-3 See general comments on claudin family 
above for claudin-1
Detected in TJs in brain endothelial cells in some studies 
(Wolburg et al., 2003) but not in others (Ohtsuki  
et al., 2008; Daneman et al., 2010a); induced  
during brain angiogenesis by canonical Wnt/ 
-catenin signaling (Liebner et al., 2008); expressed 
in choroid plexus epithelial cells and localizes to TJs 
(Wolburg et al., 2003; Kratzer et al., 2012; Kooij 
et al., 2014)
Expression is induced during brain 
angiogenesis and correlates with 
barriergenesis (Liebner et al., 2008); 
sealing of BCSFB but not BBB TJs under 
neuroinflammatory conditions as de-
tected in claudin-3–deficient mice (Kooij 
et al., 2014)
Claudin-5 Endothelial cell–specific component of TJ 
strands (Morita et al., 1999)
Highly expressed in BBB TJs in zebrafish, rodents, 
nonhuman primates, and humans (Nitta et al., 
2003; Jeong et al., 2008; Hoshi et al., 2013); 
junctional localization in zebrafish BCSFB (Henson 
et al., 2014)
Claudin-5–deficient mice do not survive 
due to BBB leakiness to molecules <800 
D (Nitta et al., 2003); focal loss of 
claudin-5 correlates with BBB dysfunc-
tion (Zhou et al., 2014)
Claudin-11 Induces parallel-array TJ strands in myelin 
sheaths of oligodendrocytes (Gow et al., 
1999); claudin-11–deficient mice develop 
neurological deficits including deafness 
(Gow et al., 1999, 2004)
Localizes to TJs of BCSFB in mice (Wolburg et al., 
2001)
TJs of the BCSFB are characterized by par-
allel running particle strands (Wolburg 
and Paulus, 2010) probably induced 
by claudin-11
Claudin-12 See general comments on the claudin family 
above for claudin-1; claudin-12 lacks a 
C-terminal PDZ-binding motif
Shown to be specifically expressed in and to localize 
to TJs of brain endothelial cells by some laboratories 
(Nitta et al., 2003; Schrade et al., 2012) but not 
by others (Ohtsuki et al., 2008; Daneman et al., 
2010a)
Function at BBB unknown
Additional claudins See general comments on claudin family 
above
mRNA and protein of additional claudins detected 
in mouse choroid plexus (Kratzer et al., 2012); 
mRNA of additional claudins detected in purified 
brain microvessels (Hoshi et al., 2013); additional 
claudin proteins detected in rat and marmoset brain 
microvessels (Ohtsuki et al., 2008)
Functions in brain barriers unknown
JAM-A (Junctional adhesion 
molecule A, JAM-1)
Type I transmembrane protein and member 
of the classical JAM family of the Ig super-
family; two extracellular Ig-like domains, 
cytoplasmic tail with a PDZ-binding motif; 
JAMs engage in homophilic and hetero-
philic interactions among their family 
members and bind integrins (Martìn-
Padura et al., 1998; for review see 
Garrido-Urbani et al., 2014)
Expressed in and localized to mouse and human BBB 
endothelial TJs (Aurrand-Lions et al., 2001b; Vorbrodt 
and Dobrogowska, 2004; Padden et al., 2007)
Regulates cell polarity by intracellular asso-
ciation with the PAR-3/atypical protein 
kinase C (aPKC)/PAR-6 complex (Ebnet 
et al., 2001) and leukocyte trafficking 
across endothelial barriers including 
the BBB (Martìn-Padura et al., 1998; 
Williams et al., 2013); loss of vascular 
JAM-A immunostaining in human brain 
tissue correlates with BBB leakiness 
(Padden et al., 2007)
JAM-B (human JAM-2;  
human and mouse  
VE-JAM; mouse JAM-3)
See explanation for JAM-A Expressed in and localized to TJs at mouse BBB 
(Aurrand-Lions et al., 2001a,b)
Leukocyte trafficking across skin endothe-
lium (Ludwig et al., 2009); function at 
brain barriers is unknown
JAM-C (human JAM-3; 
mouse JAM-2)
See explanation for JAM-A Localizes to TJs in mouse BBB and BCSFB (Arrate et al., 
2001; Wyss et al., 2012)
Might contribute to human BBB integrity 
(Mochida et al., 2010); JAM-C/ 
C57BL/6 mice develop a hydrocepha-
lus independent of endothelial JAM-C, 
suggesting that JAM-C at the BCSFB 
might influence brain fluid homeostasis 
(Wyss et al., 2012)
Transmembrane proteins 
outside of organized AJs 
and TJs
PECAM-1 Type I integral membrane protein of the 
Ig superfamily with six extracellular Ig 
domains, a short transmembrane, and 
a long cytoplasmic domain that can be 
serine and tyrosine phosphorylated upon 
cellular activation; highly expressed in all 
endothelial cells (summarized in Privratsky 
and Newman, 2014)
Highly expressed in endothelial cell-to-cell junctions 
outside of organized AJs and TJs, including the BBB 
(Graesser et al., 2002; Lyck et al., 2009)
Contributes to steady-state barrier function 
of endothelial cells; functions as a mech-
anosensor and accelerates restoration 
of barrier integrity following perturba-
tions, including the BBB (Graesser et al., 
2002; Privratsky and Newman, 2014)
CD99 and CD99L Heavily O-glycosylated type I transmem-
brane proteins (Schenkel et al., 2002)
Localizes to endothelial cell-to-cell contacts including 
those of brain endothelial cells (Bixel et al., 2004).
Immune cell trafficking across brain endo-
thelium in vitro (Bixel et al., 2004)
Table 1. Expression and known function of junctional molecules at brain barriers (Continued)
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2011). This study demonstrated that, during brain angiogenesis, 
Shh is secreted by immature astrocytes, and that lack of the Shh 
signal transducer Smoothened (Smo) in CNS endothelial cells 
leads to reduced expression of the TJ proteins occludin, claudin-3, 
and claudin-5, but also of ZO-1 and p120-catenin, which was ac-
companied by increased leakage of plasma tracers in the develop-
ing BBB. By regulating expression of p120-catenin, the Shh 
pathway might influence maturation of both CNS endothelial AJs 
and TJs. At the same time, this study provided in vitro evidence 
that Shh increases the expression of the TJ proteins occludin, 
claudin-3, claudin-5, and JAM-A in human brain endothelial 
cells (Alvarez et al., 2011). Another single study that awaits con-
firmation showed that astrocyte-derived SSeCKS (Src-suppressed 
C-kinase substrate) contributes to CNS endothelial junctional 
maturation by regulating the release of astrocyte-derived Ang-1, 
which, by binding to its receptor Tie-2 on the CNS endothelial 
cells, increases expression of the TJ proteins occludin, claudin-1, 
ZO-1, and ZO-2 in human endothelial cells (Lee et al., 2003).
A further step in the maturation of the BBB is the inter-
action of endothelial cells from nascent vessels with pericytes. 
understood. Wnt ligands produced by immature neuroectoder-
mal cells bind to Frizzled receptors (Fzd) on CNS vascular en-
dothelial cells, inducing canonical Wnt signaling. This leads to 
translocation of -catenin into the nucleus of brain endothelial 
cells resulting in the induction of BBB-specific gene transcrip-
tion, including the TJ protein claudin-3 (Liebner et al., 2008; 
Stenman et al., 2008; Daneman et al., 2009). In addition, the death 
receptors TROY (TNFRSF19) and DR6 (TNFRS21), which 
are downstream targets of the Wnt/-catenin signaling path-
way and thus involved in brain angiogenesis in mice and zebrafish 
(Tam et al., 2012), have been linked to regulating expression 
of ZO-1 in brain endothelial cells. Other factors such as the 
alternative Frizzled-4 ligand Norrin or GPR 124, an orphan 
member of the G protein–coupled receptor family, which are 
coactivators of the canonical Wnt/-catenin signaling pathway 
in nonoverlapping CNS regions, also contribute to the induction 
of BBB-specific junctional molecules such as claudin-5 (Zhou 
and Nathans, 2014; Zhou et al., 2014).
The Sonic hedgehog (Shh) pathway has also been impli-
cated in brain angiogenesis and BBB maturation (Alvarez et al., 
Junctional molecule General characteristics Brain barrier expression/localization Function in cell-to-cell contacts
Intracellular scaffolding 
proteins of AJs
p120-catenin Armadillo-repeat protein (Harris, 2012); 
binds to the juxtamembrane region of 
the cytoplasmic domain of both VE- and 
E-cadherin
Detected at ultrastructural level in AJs in human brain 
microvessels (Vorbrodt and Dobrogowska, 2004)
Stabilizes AJs by inhibiting constitutive 
endocytosis of cadherins; regulates 
activity of Rho family GTPases and thus 
actin cytoskeleton dynamics; recruits 
microtubules to the cadherin complex 
(Vestweber, 2015)
-Catenin Armadillo repeat protein (Harris, 2012); 
binds to the distal region of the cytoplas-
mic domain of VE- and E-cadherin and 
mediates interaction with -catenin that 
engages F-actin, thus linking the AJ com-
plex with the actin cytoskeleton (Buckley 
et al., 2014)
Localizes to AJs of BBB in chicken and mouse (Liebner 
et al., 2000a) and to AJs of BCSFB in rats (Lippoldt 
et al., 2000); early association with endothelial 
N-cadherin during brain angiogenesis followed by 
junctional localization (Liebner et al., 2000a); local-
izes to endothelial nuclei during brain angiogenesis 
to regulate transcription (summarized in Engelhardt 
and Liebner, 2014)
Stabilizes AJs by inhibiting proteolysis of 
cadherins (Vestweber, 2015); regu-
lates BBB differentiation during brain  
angiogenesis by inducing expression  
of claudin-3 via the canonical Wnt/ 
-catenin signaling pathway (summa-
rized in Engelhardt and Liebner, 2014)
-Catenin (plakoglobin) Binds to the cytoplasmic tail of VE-cadherin Shown to localize to AJ of BBB in chickens (Liebner et 
al., 2000a)
Links cadherin complex to intermediate 
filaments
-Catenin -Catenin binds directly or indirectly to  
-catenin and to the actin cytoskeleton
Localizes at the ultrastructural level to interendothelial 
junctions of vessels in human or mouse brain tissue 
sections (Vorbrodt and Dobrogowska, 2003); local-
izes to AJs at rat BCSFB (Lippoldt et al., 2000)
Anchors AJs to the actin cytoskeleton; regu-
lates the adhesive function of cadherins 
(summarized in Vestweber, 2015)
Intracellular scaffolding 
protein TJs
ZO-1 (Zonnula occludens -1) TJ scaffolding protein of the MAGUK (mem-
brane associated with a guanylyl kinase-
like domain) family; binds to integral TJ 
proteins, ZO-2, and F-actin (for review 
see Van Itallie and Anderson, 2014).
Localizes to BBB junctions in mouse (Nico et al., 1999) 
and human brain tissue (Kirk et al., 2003; Vorbrodt 
and Dobrogowska, 2003); localizes to TJs in mouse 
BCSFB (Wolburg et al., 2001; Kratzer et al., 2012); 
also localizes to AJs by binding to -catenin and 
F-actin (Itoh et al., 1999)
ZO-1 organizes components of TJs in epi-
thelial cells as well as both TJs and AJs 
in endothelial cells, and links them to 
the cortical actin cytoskeleton (Fanning 
et al., 1998; Itoh et al., 1999); central 
regulator of VE-cadherin–dependent AJs 
(Tornavaca et al., 2015)
ZO-2 TJ scaffolding protein of the MAGUK family Associates with junctions in primary bovine and human 
brain microvascular endothelial cells in vitro (Mark 
and Davis, 2002; Lee et al., 2009); ZO-2 mRNA 
detected in choroid plexus of mice (Kratzer et al., 
2012)
Can replace ZO-1 in TJs
ZO-3 TJ scaffolding protein of the MAGUK family Low mRNA expression levels in mouse choroid plexus 
and brain microvascular endothelial cells (Kratzer  
et al., 2012) and mRNA and protein detected in 
choroid plexus of ewes (Lagaraine et al., 2011)
Can replace ZO-1 and ZO-2 in TJs
Table 1. Expression and known function of junctional molecules at brain barriers (Continued)
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Maintenance of junctional complexes  
at mature brain barriers
A combination of transcriptome and proteome analyses of the 
BBB and the BCSFB (Huntley et al., 2014), the development of 
antibodies to detect the subcellular localization of the individual 
molecular components of junctions, as well as high-resolution 
imaging have improved our knowledge of the junctional archi-
tecture of BBB endothelial cells and the choroid plexus epithelial 
cells (Fig. 1 and Table 1). Choroid plexus epithelial cells seem 
to maintain their unique barrier characteristics, including proper 
junctional complexes, when removed from the CNS and put in 
culture (Gath et al., 1997; Strazielle and Ghersi-Egea, 1999; 
Schroten et al., 2012). However, endothelial cells forming the 
BBB need pericytes and astrocytes as well as the extracellular 
matrix surrounding the BBB endothelium to maintain their unique 
barrier characteristics (Wolburg et al., 1994; Liebner et al., 2000b). 
Adhesive contacts between pericytes and endothelial cells are 
provided by N-cadherin, which in this case is not restricted to 
AJs (Gerhardt et al., 2000). Studies in viable pericyte-deficient 
mouse mutants have shown that pericytes do not directly affect 
BBB junctional architecture but rather regulate barrier character-
istics of CNS endothelial cells by inhibiting transcellular vesic-
ular trafficking and inducing astrocyte polarity (Armulik et al., 
2010; Daneman et al., 2010b). However, astrocyte-derived fac-
tors seem to maintain junctional integrity of the BBB endothe-
lium. Indeed, toxin-induced deletion of GFAP+ astrocytes in 
certain brain regions in mice and rats was found to induce a revers-
ible focal dysfunction of the BBB (Bush et al., 1999; Willis et al., 
2013) that is accompanied by the loss of junctional localization 
of claudin-5 and altered phosphorylation of occludin in brain en-
dothelium (Willis et al., 2013). Interestingly, although junctional 
localization of VE-cadherin and -catenin was found unchanged 
in the latter study, expression of VE-cadherin was up-regulated, 
underlining the tight connection between regulating BBB AJs 
and TJs. The molecular cues provided by astrocytes to maintain 
junctional integrity of the BBB are not well understood.
In addition to its role in BBB development, recent studies 
support a role of the canonical Wnt/-catenin signaling pathway 
in BBB maintenance and thus probably in sustaining junctional 
integrity. Using novel transgenic reporter lines to visualize Wnt/ 
-catenin signaling in zebrafish allowed for the demonstration of 
Wnt/-catenin signaling activity in CNS vessels of adult 
zebrafish (Moro et al., 2012). Furthermore, elegant gain- and loss-
of-function mouse mutants for Norrin/Fz4 signaling show a 
cell-autonomous gain or loss of BBB function accompanied by 
the presence or absence of claudin-5 expression, respectively, in 
the cerebellum of these mice, which supports the continuous re-
quirement of Frizzled signaling in preserving the mature BBB 
junctional structure (Wang et al., 2012; Zhou et al., 2014).
Finally, components of the basement membranes have re-
cently been shown to contribute to junctional integrity of brain 
endothelial cells (Fig. 2). The heparan sulfate proteoglycan agrin 
contributes to barrier properties of brain endothelial cells by sta-
bilizing junctional localization of molecules forming AJs rather 
than TJs (Steiner et al., 2014). Using mouse models in which 
1-integrins are specifically inactivated in endothelial cells, 
Yamamoto et al. (2015) showed that the absence of this integrin 
Pericytes are recruited to the sprouting CNS vessels during brain 
angiogenesis and contribute to BBB maturity including the regu-
lation of astrocyte polarity (Armulik et al., 2010; Daneman 
et al., 2010b). In addition to the homophilic interaction between 
endothelial and pericyte N-cadherins, platelet-derived growth 
factor-B (PDGF-B) secreted by endothelial cells and its recep-
tor PDGFR- on the pericytes regulates pericyte/endothelial 
interaction (summarized in Siegenthaler et al., 2013). In contrast 
to astrocyte-derived factors, pericytes seem to have no influence 
on the maturation of BBB AJs and TJs, as pericyte-deficient mice 
develop a normal BBB TJ architecture (Armulik et al., 2010), 
while showing increased BBB leakiness due to, surprisingly, 
increased vesicular trafficking across CNS endothelial cells. Thus, 
pericytes seem to inhibit vesicular transport across the BBB 
endothelium. This has recently been underlined by the finding 
that Mfsd2a (major facilitator super family domain containing 
2a) is specifically induced in CNS endothelial cells by endo-
thelial/pericyte interactions and suppresses transcytotic activity 
in CNS endothelial cells, thus contributing to BBB maturation 
(Ben-Zvi et al., 2014).
Interepithelial junctions at the developing 
BCSFB. Although there are numerous studies dedicated to the 
investigation of barrier integrity of the BCSFB during embry-
onic development, few studies have specifically addressed mat-
uration of cell-to-cell junctions in choroid plexus epithelial cells 
and whether this correlates with the barrier properties of the 
BCSFB. Complex TJs have been visualized by freeze-fracture 
and transmission electron microscopy during very early human 
and sheep fetal development, at a time when peripheral tracers 
were still found to diffuse across BCSFB obviously via a trans-
cellular route (Møllgård and Saunders, 1975). These observa-
tions indirectly imply that BCSFB AJs connect choroid plexus 
epithelial cells early during development before barrier matu-
ration. More recent studies that focused on investigating ex-
pression of TJ proteins during embryonic development showed 
expression of occludin and MarvelD3 in the choroid plexus of 
mouse embryos (Diez-Roux et al., 2011), while in rats early and 
high expression levels of up to 10 different claudins as well as 
of occludin and ZO-1, ZO-2, and ZO-3 were observed and thus 
suggest the early development of mature TJ complexes at the 
BCSFB (Kratzer et al., 2012; Liddelow et al., 2013). Specifically, 
in addition to claudin-1, claudin-2, claudin-3, and claudin-11, 
these studies discovered expression of claudin-9, claudin-19, 
and claudin-22 in choroid plexus epithelial cells.
Investigation of the maturation of the BCSFB in zebra-
fish demonstrated that this barrier becomes functional starting 
at day 2 postfertilization as shown by reduced leakage of dif-
ferent sized tracers (Henson et al., 2014). Interestingly, this 
study also describes immunostaining for claudin-5, which in 
rodents has been found to be specifically expressed in endo-
thelial cells, in the choroid plexus epithelium (Henson et al., 
2014). Considering its proposed role in BBB maturation, one 
of the signaling pathways involved in regulating junctional 
maturation in the BCSFB might be the Shh pathway, which 
was found to be critical in the continual growth and expan-
sion of the hindbrain choroid plexus throughout development 
(Huang et al., 2009).
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BCSFB are intrinsically more stable, as indicated by the forma-
tion of mature AJs and TJs in cultured choroid plexus epithelial 
cells (Gath et al., 1997; Strazielle and Ghersi-Egea, 1999). 
However, besides providing the BCSFB, the choroid plexus has 
been suggested to regulate access of hormones to the CSF. In 
this context, a study performed in sheep has demonstrated 
photoperiod-dependent regulation of the expression levels of occlu-
din, ZO-1, ZO-2, afadin, and E-cadherin in the choroid plexus 
in correlation with the regulation of the passage of hormones 
into the brains of the sheep (Lagaraine et al., 2011). This study 
therefore provides evidence for a physiological and dynamic 
regulation of junctional complexes at the BCSFB.
Neuroinflammation: junctional complexes at 
dysfunctional brain barriers
Neuroinflammation is generally accompanied by impaired BBB 
and BCSFB function, which includes alterations in their junc-
tional complexes. For example, in the vascular dysplasia referred 
to as cerebral cavernous malformation (CCM), loss-of-function 
mutations in CCM-1, CCM-2, or CCM-3, which localize gener-
ally to AJs, primarily affect brain vessels. CCMs form a tripar-
tite complex that associates with -catenin and afadin at AJs. 
reduced the interaction between VE-cadherin and p120-catenin, 
causing an increase in the internalization of VE-cadherin. Thus, 
1-integrin–mediated binding of CNS endothelial cells to the 
extracellular matrix is critical for stabilizing junctional local-
ization of VE-cadherin and vascular integrity (Yamamoto et al., 
2015; Fig. 2). The molecular processes identified to be down-
stream of endothelial 1-integrin involved myosin light chain 
phosphorylation by the GTPase Rap1 and the kinase MRCK in 
addition to Rho/Rho-kinase signaling. In light of the previous 
observations that junctional localization of VE-cadherin regu-
lates expression and junctional localization of claudin-5 (Taddei 
et al., 2008), it is interesting to note that endothelial cell ma-
trix interactions via endothelial 1-integrins were also found to 
increase expression and junctional localization of claudin-5 to 
BBB TJs (Osada et al., 2011; Fig. 2). In addition, laminin 2, 
which is part of the astrocyte-derived parenchymal basement 
membrane and thus critical for astrocyte polarity, influences 
BBB TJ morphology and barrier function, as recently observed 
in laminin 2–deficient mice (Menezes et al., 2014).
In contrast to the BBB TJs, not much is known about fac-
tors regulating junctional integrity at the BCSFB. In general, 
junctional complexes of epithelial cells including those of the 
Figure 2. Loss of endothelial–matrix interactions in neuroinflammation affects junctional integrity of the BBB. (A) Under physiological conditions, BBB 
endothelial cells are anchored via 1-integrins to the ECM proteins laminin, collagen, and perlecan in the endothelial basement membrane. 1-integrin–mediated 
adhesive contacts contribute by not-yet-defined downstream signaling events to junctional stabilization. (B) After ischemic stroke, edema formation and BBB 
breakdown is associated with loss of vascular 1-integrin, probably by shedding or degradation (indicated by a question mark). Genetic or functional 
inactivation of 1-integrin at the BBB induces BBB leakiness by reducing the association of p120 and -catenin with VE-cadherin. This leads to increased 
internalization of VE-cadherin via clathrin-coated pits and ultimately loss of junctional claudin-5. BM, basement membrane.
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microvessels in preactive and active inflammatory lesions in 
postmortem brain tissues of MS patients, which supports the 
notion that both BBB AJs and TJs are impaired in MS and that 
alterations in the molecular composition of TJs are early events 
in BBB dysfunction during MS (Alvarez et al., 2015). A possi-
ble molecular mechanism behind these junctional changes 
might be the loss of 1-integrin–mediated anchorage of brain 
endothelial cells to the basement membrane, as observed in 
stroke (Osada et al., 2011), leading to the internalization of VE-
cadherin and claudin-5 as outlined earlier (Fig. 2). In addition, 
loss of claudin-5 and occludin at the BBB during EAE was 
found to correlate with increased expression of caveolin-1 and 
increased leakage of FITC-dextran across the BBB, which sug-
gests that caveolae-mediated endocytosis of claudin-5 and oc-
cludin contributes to BBB TJ breakdown in EAE (Errede et al., 
2012). Another molecule that has been shown to induce disrup-
tion of BBB TJs during neuroinflammation by down-regulating 
claudin-5 and occludin is VEGF, expression of which is signifi-
cantly up-regulated in astrocytes during EAE and MS (Argaw 
et al., 2009, 2012). In peripheral vascular beds, VEGF induces 
tyrosine phosphorylation of VE-cadherin, leading to disruption 
of p120-catenin and -catenin binding, subsequent internaliza-
tion and degradation of VE-cadherin, and thus increased vascu-
lar permeability (summarized in Goddard and Iruela-Arispe, 
2013). In contrast to peripheral vascular beds, the BBB endo-
thelium responds to VEGF-A in a highly polarized fashion—
e.g., only abluminal from the CNS, but not luminal VEGF-A, 
induces increased BBB permeability by activation of p38 MAPK 
and loss of junctional localization of claudin-5 (Hudson et al., 
2014). Thus, in neuroinflammation, astrocyte-derived factors 
seem to be instrumental in regulating BBB junctional integrity. 
This is further supported by the observations that BBB dysfunc-
tion is associated with loss of astrocyte polarity. This is visual-
ized by the decrease of the polarized localization of the water 
channel aquaporin 4 (AQP4) from astrocyte end-feet in EAE 
and other neurological disorders such as stroke and glioblas-
toma multiforme (Wolburg-Buchholz et al., 2009). Loss of 
astrocyte polarity suggests loss of polarized secretion of other 
astrocyte-derived factors such as Shh, Wnts, and Norrin that 
support appropriate expression and localization of BBB junc-
tional molecules. Indeed, up-regulated expression of Shh in 
hypertrophic astrocytes in active demyelinating MS lesions 
was accompanied by increased expression of the Shh receptor 
Patched-1 and nuclear translocation of the Shh pathway tran-
scription factor Gli-1 in BBB endothelial cells (Alvarez et al., 
2011). These observations suggest that neuroinflammation acti-
vates the Shh pathway at the level of the BBB, thereby possibly 
promoting BBB repair.
The concept that neuroinflammation might reactivate path-
ways operative during the maturation of BBB junctional com-
plexes in embryonic development is further supported by the 
recent observations that retinoic acid (RA) contributes to BBB 
maturation. Radial glial cells in fetal human brain tissue were 
found to express high levels of the RA-producing enzyme reti-
naldehyde dehydrogenase 2 (RALDH2) and to tightly associate 
with the developing brain vasculature expressing the RA recep-
tor  during embryogenesis (Mizee et al., 2013). In vitro studies 
By regulating the small GTPase Rap-1 (CCM-1) and the Rho 
GTPase pathway (CCM-2), they contribute to junction stabiliza-
tion and endothelial cell polarity (Dejana and Orsenigo, 2013). 
Mutations in CCM proteins lead to endothelial–mesenchymal 
transition, which is characterized by loss of VE-cadherin, up-
regulated expression of N-cadherin, and the accompanying loss 
of endothelial cell polarity (Maddaluno et al., 2013). Thus, even 
though the CCM genes are mutated in endothelial cells through-
out the body, barrier function of brain endothelial cells seems to 
more critically rely on the adhesive properties of VE-cadherin to 
stabilize cell polarity (Dejana and Orsenigo, 2013).
Disruption of BBB and BCSFB function also contributes 
to neurological disorders such as stroke or multiple sclerosis 
(MS) and its animal model experimental autoimmune encepha-
lomyelitis (EAE). MS is an inflammatory demyelinating dis-
ease of the CNS, in which immune cells cross the BBB and the 
BCSFB causing CNS inflammation, edema formation, and 
brain barrier dysfunction. In fact, early lesion formation in MS 
is associated with focal BBB dysfunction as visualized by 
gadolinium-enhanced magnetic resonance imaging (Kermode 
et al., 1990), which is used as a diagnostic criterion for this disease. 
A series of immunofluorescence studies of postmortem brain 
samples from MS patients have convincingly demonstrated that 
an abnormal distribution of the TJ proteins occludin, JAM-A, 
and ZO-1 but not of the AJ protein -catenin correlates with the 
premortem pattern of perivascular serum protein leakage in ac-
tive MS lesions (Plumb et al., 2002; Kirk et al., 2003; Padden 
et al., 2007). These data therefore strongly support a contribu-
tion of TJ disruption to BBB dysfunction in MS. Based on 
immunostainings for ZO-1, BBB junction alterations as observed 
in MS are quite reliably modeled in brain tissues of mice after 
induction of EAE (Bennett et al., 2010). Using the EAE model, 
a critical function for BBB TJs in maintaining barrier functions 
of the BBB in neuroinflammation has been further supported by 
the observation that inducible endothelial cell–specific ectopic 
expression of claudin-1 ameliorated clinical symptoms of EAE 
in mice by specifically blocking BBB leakiness without affect-
ing immune cell migration into the CNS (Pfeiffer et al., 2011). 
Immune cell infiltration into the CNS during EAE might, how-
ever, add to BBB TJ pathology, as further studies in the EAE 
model showed the selective loss of claudin-3 or claudin-5 immuno-
staining in brain and spinal cord microvessels surrounded by in-
flammatory infiltrates (Wolburg et al., 2003; Paul et al., 2013). 
Loss of immunostaining for an individual TJ protein is, how-
ever, not predictive for a dysfunctional BBB, as recent studies 
on EAE pathogenesis in claudin-3–deficient mice failed to de-
fine a role for claudin-3 in maintaining BBB integrity or regulat-
ing leukocyte infiltration into the CNS during EAE (Kooij et al., 
2014). Also, considering the known function of claudin-5 in regu-
lating the diffusion of small molecules (<800 D) across the BBB, 
specific loss of claudin-5 immunostaining in BBB TJs can hardly 
be the equivalent of BBB leakiness for large serum proteins 
such as fibrinogen into the CNS parenchyma. Rather, these ob-
servations suggest that the loss of additional junctional compo-
nents is mandatory for an impairment of BBB function as observed 
in MS and EAE. Indeed, a recent study has found severe loss of 
both the TJ protein claudin-5 and the AJ protein VE-cadherin in 
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Concluding remarks
Despite great progress in our understanding of the molecular 
composition of brain barrier junctions, research in the field has 
mostly focused on studying brain barrier TJs. There is now 
strong experimental evidence for crosstalk between AJs and 
TJs influencing their stability and dynamics at a structural and 
transcriptional level. Beyond their structural functions, AJs and 
TJs have emerged as central regulators of intracellular signaling 
pathways that regulate cytoskeletal dynamics. Thus, their coop-
eration is central to the control of morphogenesis and homeo-
stasis. Perturbation of these junctional complexes at the level 
of the brain barriers thus disrupts CNS homeostasis and is as-
sociated with neurological disorders. There is evidence that 
protecting the brain barriers by specifically improving junc-
tional integrity is beneficial in animal models for MS or stroke 
(Pfeiffer et al., 2011; Wacker et al., 2012). Considering the re-
cent findings that circulating sphingosine-1-phosphate (S1P) 
stabilizes vascular junctions via downstream signaling through 
its G-protein–coupled receptor S1P1, which influences the 
cortical actin cytoskeleton (summarized in Goddard and Iruela-
Arispe, 2013), it is tempting to speculate that therapeutic ef-
ficacy of the S1P1 agonist fingolimod in MS patients also relies 
on stabilizing the BBB. Therefore, future research needs to go 
beyond studying the role of individual TJ proteins at the brain 
barriers. A more integrated cell biological view on the dynamic 
collaboration of AJs and TJs and how they regulate junctional 
dynamics and downstream signaling events is required to im-
prove our understanding of how these junctional complexes es-
tablish cell polarity and maintain barrier properties of the BBB 
and the BCSFB.
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